top of page

Cervical Cancer Screening

Cervical cancer occurs when abnormal cells on the cervix grow out of control. This results in an excessive accumulation of cells which eventually form a lump - a tumor. Cervical cancer can often be successfully treated when it’s found early. It is the third most common cancer among Malaysian women. 

Most women diagnosed with cervical cancer are those who screens irregularly or have never been screened for it. Human Papillomavirus (HPV) is the main cause of cervical cancer. It is known to cause cell changes in the cervix and may lead to the development of cervical cancer.

How to prevent cervical cancer:

Cervical cancer can be prevented by undergoing regular screening through co-testing of Liquid Based-Cytology (LBC) and HPV DNA Genotyping Test.


- HPV DNA Test is a test to detect and determine     the Human Papillomavirus (HPV) strain which is       the main cause of cervical cancer.
- The test enables early detection of cervical cancer
by detecting the presence of HPV even before cell   changes in the cervix have occurre

Liquid Based Cytology (LBC)

-  Liquid-Based Cytology (LBC) is the new cervical   cell collection technique developed from the
conventional method, the Pap smear.

-  LBC screens for cell changes or the presence
of abnormal or pre-cancerous cells that can be         effectively treated to prevent cervical cancer

The Advantages of Combined LBC + HPV DNA Test:

• Better detection
Co-testing increased the detection of cervical cancer

• Better management
If tested positive for HPV but LBC indicates no cell changes, condition can be closely monitored.

• Cost effective
Co-testing using the combination of cytology plus HPV DNA testing is the appropriate screening for women >30 years old. If tested negative for both tests, the screening interval is no sooner than 3 years        
subsequently. (NCCN Guidelines Version 1.2011 Cervical Cancer Screening)

Advantages of 2-in-1 Screening Test:
bottom of page